Company Profile
LaCrosse Laboratories was formed in September 2006 with the mission of manufacturing and offering for sale novel low molecular weight chemical building blocks for the pharmaceutical industry. The company strives to offer materials that are not otherwise available, saving the pharmaceutical chemist preparation time and providing novelty and diversity to his or her final products. The company also is dedicated to providing these on a timely basis so that these materials are available to the chemist when they are needed. Hence, all listed products are normally available in stock for immediate shipping.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
1H-Pyrrole-2,5-dione,1-(3-chlorophenyl)- |
AURORA12546;AKOSB006724;AKOSMSC-0022;ASISCHEMD48958;ART-CHEM-BBB006724;1-(-3-CHLOROPHENYL)MALEIMIDE;1-(3-CHLORO-PHENYL)-PYRROLE-2,5-DIONE;1-(3-CHLOROPHENYL)-1H-PYRROLE-2,5-DIONE;1H-pyrrole-2,5-dione,1-(3-chlorophenyl)-;1-(3-chlorophenyl)-3-pyrroline-2,5-quinone |
1204-35-9 | Inquiry | |
1H-Pyrrole-2,5-dione,1-(4-chlorophenyl)- |
1H-Pyrrole-2,5-dione,1-(4-chlorophenyl)-;Maleimide,N-(p-chlorophenyl)-;1-(4-Chlorophenyl)-1H-pyrrole-2,5-dione;N-(p-Chlorophenyl)maleimide;N-(4-Chlorophenyl)maleimide;NSC 52612;NSC 55657;NSC 63150;1-(4-Chlorophenyl)-pyrrole-2,5-dione;p-Chlorophenylmaleimide;1-(4-Chlorophenyl)-2,5-dihydro-1H-pyrrole-2,5-dione;N-(4-Chlorophenyl)maleic imide |
1631-29-4 | Inquiry | |
1H-Pyrrole-2,5-dione,1-(4-fluorophenyl)- |
AKOS MSC-0027;ASISCHEM N13878;N-(4-FLUORO-PHENYL)MALEIMIDE;1-(4-FLUORO-PHENYL)-PYRROLE-2,5-DIONE;1-(4-FLUOROPHENYL)-1H-PYRROLE-2,5-DIONE;1-(4-Fluorophenyl)-3-pyrroline-2,5-dione;1H-Pyrrole-2,5-dione, 1-(4-fluorophenyl)- |
6633-22-3 | Inquiry | |
2-Propenoic acid,3-iodo-, (2E)- |
(E)-3-IODOACRYLIC ACID;(E)-3-Iodo-2-propenoic acid;2-propenoic acid, 3-iodo-, (2E)-;3-iodo-2E-acrylic acid;3-Iodoacrylic acid;(E)-3-iodoprop-2-enoic acid;3-iodo-2E-propenoic acid;(Z)-(3)-Iodoacrylic acid;b-iodoacrylic acid;PubChem11671 |
6372-02-7 | Inquiry |
CONTACT INFORMATION
Sign In for Details